RPS maintains support for up to 12-week dosing interval between COVID-19 vaccines

The Royal Pharmaceutical Society has said it maintains its support for leaving up to 12 weeks between administering doses of the COVID-19 vaccines.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research